Press Releases

Company Achieves 97% U.S. Customer Overall Satisfaction Rating Two Regional Sales Managers Added to Strengthen U.S. Sales Team BOTHELL, WA - April 4, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced the results of an independently conducted survey designed to monitor and track satisfaction levels of its U.S. customers regarding the Sonosite TITAN„¢, 180PLUS and 180 ELITE product lines. Customers gave their Sonosite products a resounding overall satisfaction rating of 97%. An overwhelming majority reported that Sonosite's hand-carried systems performance met or surpassed expectations relative to image quality, ease of use, durability, reliability and ergonomic design of transducers. The survey also reported that four out of five customers believe that the image quality of their Sonosite systems is either equal to or better than other ultrasound products."As the leader in the rapidly growing hand carried ultrasound market, customer satisfaction is a top priority," said Kevin M. Goodwin, Sonosite President and CEO. "We believe that our industry leading technology and dedicated focus will allow us to continue to achieve high satisfaction ratings with our customers and remain at the forefront of this market."Verispan, an independent health care information research firm, conducted the company-commissioned survey.

Fully Featured Hand-Carried Ultrasound System ProvidesComplete Capabilities for Echo Studies;New Capabilities Address $460 Million International Shared Services MarketNEW ORLEANS, March 8, 2004 - Sonosite, Inc. (Nasdaq: SONO), the worldwide leader in high-performance, hand-carried ultrasound, today announced at the American College of Cardiology ACC 53rd Annual Scientific Session that it is adding cardiology capabilities to the TITAN system, the company's newest generation, high-resolution, hand-carried system that enables ultrasound to be available quickly wherever and whenever it is needed. Customer deliveries are scheduled for mid-June; current customers will be able to upgrade to the enhanced TITAN system capabilities. Sonosite will be introducing these new TITAN capabilities in Booth #344 during ACC in New Orleans from March 7-10.

Fourth Quarter revenue increases to $27.3 millionFourth quarter profitability grows to $2.2 million or $0.15/shareSubsidiaries to open in Japan, Australia and CanadaBOTHELL, WA, February 12, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced increased revenue, gross margin and net income for the fourth quarter ended December 31, 2003 as compared with the fourth quarter of 2002.Revenue in the fourth quarter of 2003 grew to $27.3 million, a 9 percent increase over the fourth quarter of 2002. For the full year 2003, revenue increased 16 percent to $84.8 million compared with $73.0 million in 2002.The Company reported that net income increased 158 percent to $2.2 million or $0.15 per share for the fourth quarter of 2003 compared with $0.9 million or $0.06 per share in the prior year quarter. For the full year 2003, Sonosite reported a net loss of $1.8 million or $0.12 per share versus a net loss of $7.7 million or $0.59 per share for 2002. As of December 31, 2003, cash, cash equivalents and investments totaled $61.0 million.

BOTHELL, January 28, 2004 - Sonosite, Inc. (NASDAQ: SONO), the leader in high-performance, hand-carried ultrasound technology, today announced the appointment of Robert G. Hauser, M.D., F.A.C.C., president, Cardiovascular Services Division of Abbot Northwestern Hospital, to its board of directors."We are delighted that Dr. Hauser, a prominent cardiologist and accomplished executive, has joined our board," said Kevin M. Goodwin, president and CEO of Sonosite. "Dr. Hauser's broad business experience and expertise in cardiovascular medicine will play a crucial role in advising the company on growth strategies as we extend our technology and sales efforts further into key markets."In addition to his position as president of the Cardiovascular Services Division at Abbot Northwestern, Dr. Hauser, 64, is a senior consulting cardiologist at the Minneapolis Heart Institute. He was formerly the director of Pacemaker Surveillance Clinic, Minneapolis Heart Institute and served as president of the Minneapolis Heart Institute. Prior to that, Dr. Hauser served as chief executive officer of Minneapolis Cardiology Associates. He also served as president and chief executive officer of Cardiac Pacemakers, Inc. from 1988 to 1991, and continued as its Chairman and CEO until 1992 following its acquisition by Guidant.